This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: University of Massachusetts, University of Toronto. Active years: 2022.
Company Filing History:
1 out of 1,623 
1 out of 529 
Years Active: 2022
Title: April Pawluk: Innovator in CRISPR Technology
Introduction
April Pawluk is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of gene editing, particularly through her work on CRISPR technology. Her innovative approach has the potential to revolutionize various applications in biotechnology, agriculture, and medicine.
Latest Patents
April Pawluk holds a patent for "Anti-CRISPR compounds and methods of use." This invention is related to CRISPR-Cas9 gene editing platforms. It identifies Type II-C Cas9 anti-CRISPR (Acr) inhibitors that control Cas9 gene editing activity. The co-administration of these Acr inhibitors may enhance the safety and practicality of biological therapeutics by allowing spatial or temporal control of Cas9 activity. This innovation also aims to manage Cas9-based gene drives in wild populations, reducing the ecological consequences of forced inheritance schemes.
Career Highlights
Throughout her career, April has worked at esteemed institutions such as the University of Massachusetts and the University of Toronto. Her research has focused on advancing gene editing technologies and their applications in various fields.
Collaborations
April has collaborated with notable colleagues, including Karen Maxwell and Alan Davidson. These partnerships have contributed to her success and the advancement of her research in CRISPR technology.
Conclusion
April Pawluk is a trailblazer in the field of gene editing, with her innovative work on anti-CRISPR compounds paving the way for safer and more effective applications of CRISPR technology. Her contributions are poised to have a lasting impact on biotechnology and related fields.